BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201028
DTEND;VALUE=DATE:20201029
DTSTAMP:20260410T033523
CREATED:20201019T120940Z
LAST-MODIFIED:20201019T120940Z
UID:18393-1603843200-1603929599@staging.medilinkmidlands.com
SUMMARY:Making Pharmaceuticals Digital Week: Medilink UK Session
DESCRIPTION:Medilink UK are delighted to be presenting during the Making Pharmaceuticals Digital Week\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nOn Wednesday\, 28 October Dr. Nicola Wall and Dr. Richard Weaver will present a live webinar on behalf of Medilink UK:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWorking with your CRO: Creating perfect research partnerships in an imperfect research world\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDr. Nicola Wall \nAfortiori Development\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nBridging The Gap Between Discovery and Development – DMPK Influence\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDr. Richard Weaver \nXenoGesis Ltd\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nThe webinar is free to attend and will start at 11.00 GMT (12.00 CET | 06.00 EST) \nYou can register to attend using the button below.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRegister for free here\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nView the Full Digital Week Programme Here
URL:https://staging.medilinkmidlands.com/event/making-pharmaceuticals-digital-week-medilink-uk-session/
CATEGORIES:Medilink Partner Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/365c5295c6f89d80b6b7d0cabc5af4f0.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201022T140000
DTEND;TZID=Europe/London:20201022T150000
DTSTAMP:20260410T033523
CREATED:20200921T121811Z
LAST-MODIFIED:20200921T121811Z
UID:18372-1603375200-1603378800@staging.medilinkmidlands.com
SUMMARY:Accessing the German HealthTech Markets Webinar
DESCRIPTION:In cooperation with Germany Trade & Invest (GTAI) SEHTA would like to invite you to a webinar highlighting market access and opportunities in Germany within the field of digital health. \nDate: Thursday 22nd October 2020 \nTimes: 14:00 – 15:00 (BST) \nCost: Free to attend \nWebinar Platform: WEBEX \n\n \nFor many years\, the digitalization of the German healthcare system was slow on the uptake.  The Covid-19 crisis has given a significant boost to digital health solutions\, which are now seen as an imperative. The pandemic has been a true catalyst for segments such as telemedicine services in Germany. And since the German E-Health Act took effect in January 2016\, a framework has been in place for the integration of information and communication technology within the German healthcare system\, making Germany’s digital health market increasingly attractive. \nThe session will provide insights into Germany’s digital health market\, including the latest market developments\, the legal framework for expanding your business to Germany\, and how GTAI can assist with this process. \nAgenda \n\n\n\nEST Time\nBST Time\nWebinar Programme\n\n\n15:00 – 15:30\n14:00 – 14:30\nMarket Opportunities in Germany – Digital Health \nJulia Pietsch\, Senior Manager of Investor Consulting\, Digital Health\, Germany Trade & Invest (GTAI)\n\n\n15:30 – 15:40\n14:30 – 14:40\nLegal Framework for expanding your business into Germany \nChristina Schön\, Senior Manager of Tax & Legal Services\, Germany Trade & Invest (GTAI) \n \n\n\n15:40 – 16:00\n14:40 – 15:00\nQ&A\n\n\n16:00\n15:00\nClose\n\n\n\nClick here to book
URL:https://staging.medilinkmidlands.com/event/accessing-the-german-healthtech-markets-webinar/
CATEGORIES:Medilink Partner Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201021T130000
DTEND;TZID=Europe/London:20201021T143000
DTSTAMP:20260410T033523
CREATED:20201019T112546Z
LAST-MODIFIED:20201019T112546Z
UID:18391-1603285200-1603290600@staging.medilinkmidlands.com
SUMMARY:MediWales: Finance and Funding Webinar
DESCRIPTION:21st October\, 1pm \nFinal call to register! \nJoin us for the first in our Business Support webinar series\, focusing on finance and funding. \nThis event will highlight sources of grant funding and advice on applications\, as well as fund raising\, pitching and working with investors. \nHear from experts across the sector and first hand company case studies. \nMediWales partners GS Verde will be introducing their new investment platform – Elevate Investment Network. Elevate connects businesses seeking investment\, with a network of experienced business investors. \nYou can find out more about the platform during the webinar\, including how a business seeking investment can apply and also how investors interested in joining the network can register. \nSpeakers include: \n\nVerde Corporate Finance – Craig Blackmore\, Director\nDevelopment Bank of Wales – Richard Thompson\, Senior Investment Executive\nKnowledge Transfer Network – Matt Chapman\, Knowledge Transfer Manager\nCapital Kinetics – Christian Kumar\, Managing Director\nThe Thought Disruptor – Tony Sedgwick\nRescape – Matt Wordley\, CEO\n\nThere will also be time for a panel discussion\, Q&A and virtual networking. \nThis webinar is free to members and £50 + VAT for non members. \nFind out more and register here
URL:https://staging.medilinkmidlands.com/event/mediwales-finance-and-funding-webinar/
CATEGORIES:Medilink Partner Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201005T080000
DTEND;TZID=Europe/London:20201005T170000
DTSTAMP:20260410T033523
CREATED:20201005T104654Z
LAST-MODIFIED:20201005T104654Z
UID:18383-1601884800-1601917200@staging.medilinkmidlands.com
SUMMARY:SEHTA & eg Technology Series of Medical Devices Product Design & Development Webinars November 2020
DESCRIPTION:SEHTA and eg Technology are delighted to be running a second series of Medical Devices Product Design & Development Webinars to enable you to continue to update your skillset and move your medical technologies and companies forward. \nEach session will run for 45 mins max at 14:00 – 14:45 (BST) \nThese webinars will be run via WEBEX – details on application \nTarget audience for these webinars are: Medical Technology Entrepreneurs\, Medical Device Software Developers\, Technology Transfer Officers\, Medical Technology University Researchers\, IVD Developers\, Business Owners\, Executives\, Product Owners\, Regulatory Specialists within a company that need to understand the overall regulatory requirements for their medical devices to enable them to place a device on the market and to maintain access. All company sizes will find it useful. \nCosts to attend: \n£50 +VAT pp per webinar for SEHTA Members \n£60 +VAT pp per webinar for Non-members \nNot a member of SEHTA – it’s free to join – https://www.sehta.co.uk/Post/sehta-membership \nBelow is a list of all available webinars with dates – you can choose as many webinars as you wish to take part in. \n\n\n\nWebinar\nSession Title\nDate\n\n\n1\nNew Product Development – First things First \n  \nWhether you are a first-time entrepreneur or part of a large medical company\, starting a new product development programme can feel like a daunting task. So where should you start? What things do you need to consider at the outset to turn your idea into reality? Starting with an overview of the product development process\, this webinar will move onto the most important\, and often the most overlooked aspect of product development – understanding the user. \n  \nTopics to be covered include: \n  \n·         The key things to consider from the outset of any development programme \n·         The importance of putting the user first \n·         How to obtain useful user insights \n·         How to leverage those insights to make a better product \n \nTuesday 10th November 2020\n\n\n\nFacilitator\nDanny Godfrey\, Co-Founder\, eg Technology \nIn 2002\, Danny and Andrew founded eg technology ltd\, a product design engineering company based in Cambridge UK. They have grown the company organically since then\, and now employ over 30 engineering and commercial staff. \nDanny’s role is to provide corporate leadership\, develop new business opportunities and oversee the technical and strategic direction of projects. He remains involved with the work that eg does\, from the initial proposal writing\, technical & creative input\, design implementation\, review processes and the early identification of development risks. Motivating staff and nurturing client relationships are important aspects of Danny’s day-to-day work – valuing and developing our team of bright\, can-do people and ensuring clients are satisfied with what eg does have been the foundations of success for the company. \nDanny is also a member of the MedTech Accelerator Awards Committee. This organisation supports and finances projects for early-stage companies in the medical sector to create future spin-out companies that aim to bring new life-enhancing technologies to market. \n \n\n\nWebinar\nSession Title\nDate\n\n\n2\nDefining User and Product Specifications During Product Development \n  \nThis webinar will cover what User Requirement Specification (URS) and Product Requirement Specification (PRS) are\, how they differ and how to define them during the product development process. The webinar will end with an interactive quiz. \n  \nTopics to be covered include: \n  \n·         What is a URS and PRS and how do they differ? \n·         What do the standards ask for? \n·         Where do the URS and PRS sit in the product design and development process? \n·         Writing the URS and PRS – best practices \n·         Things to watch out for \n·         Interactive quiz \n \nTuesday 17th November 2020\n\n\nFacilitator\nKella Kapnisi\, Project Manager\, eg Technology \nKella works as part of the project management team. She is responsible for delivering projects from concept through to production\, on time and within budget. Working closely with clients to ensure successful projects across a wide range of products\, including medical devices\, IVDs\, lab equipment & consumer products.  \n  \nKella is also involved in strategic reviews of project operations\, to ensure efficiency in our internal engineering design processes. She led the implementation of the requirement specification process at eg technology\, which forms part of our Quality Management System and she delivered the resultant company-wide training sessions. \n  \nKella has a background in polymer chemistry and a PhD in biomaterial engineering\, under Prof Molly Stevens at Imperial College London\, where she developed tissue engineered cardiac patches for treating heart attacks. Prior to joining eg technology\, Kella was part of a start-up developing implantable heart assist pumps. \n \n\n\n\nWebinar\nSession Title\nDate\n\n\n\n3\nSoftware Design for Medical Devices \n  \nThis webinar will cover Software Design for Medical Devices\, starting with a quick overview to medical device classification\, international standards and the role of IEC 62304. This webinar is intended to look in more detail at some practical applications of the software development processes and what it actually means for the engineers \n  \nTopics to be covered include: \n  \n·         Medical Device Classification & IEC 62304 – a quick refresher \n·         What makes software development different? \no    Software Development \no    Software Testing \no    Software Updates \n·         Structuring software development in practise \no    How to limit the scope of large software projects? \no    Where to draw a boundary around the software components? \no    How to maintain flexibility to update without major retesting/resubmission \no    Software decomposition of safety critical items \n·         Software maintenance considerations \no    What are the regulators worried about? \no    When is a bug not a bug? \n \nTuesday 24th November 2020\n\n\n\nFacilitator\nDavid Warwick\, Director\, eg Technology \nDavid joined eg in 2009 and was appointed as a Director of the company in 2019. As a Director\, he has an overall responsibility for bringing in new business to eg technology and works with the senior management team to constantly evaluate how the business operates to ensure that the company’s strategies support the future growth of eg.  \n  \nDavid’s technical background is in Software Engineering and Electronic Design with over 15 years’ experience in developing medical and IVD device software. During his time at eg technology he has helped numerous clients with the compilation of their technical files and the CE marking and FDA approval of medical devices and IVDs as well as outsourcing final product manufacture. His experience with software development includes extensive experience working with IEC 62304 across all software safety classifications. \n \n\n\n\n For more information on each webinar and to register please click below \n Click Here
URL:https://staging.medilinkmidlands.com/event/sehta-eg-technology-series-of-medical-devices-product-design-development-webinars-november-2020/
CATEGORIES:Medilink Partner Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201001T100000
DTEND;TZID=Europe/London:20201001T110000
DTSTAMP:20260410T033523
CREATED:20200923T090623Z
LAST-MODIFIED:20200923T090623Z
UID:18378-1601546400-1601550000@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Manufacturing Face Masks and PPE - what you need to know
DESCRIPTION:SGS Webinar demystifies face mask and PPE Certification for manufacturers \nSGS’s webinar\, in association with Medilink Midlands\, will explain in simple terms the steps that manufacturers must take to place personal protective equipment (PPE) and face masks on the market. \nThe pandemic has led to exponential growth in PPE demand\, with the market now projected to reach $85.72 billion (£67.87 billion) by 2026 according to Fortune Business Insights – a compound annual growth rate of 7.3%. \nTo take advantage of this lucrative market\, many companies are pivoting to include PPE manufacturing in their products and services or expanding into new geographies\, such as overseas manufacturers entering the UK market. Lancashire Textiles\, for example\, has switched from producing duvets\, blankets\, and towels to manufacturing face masks. 3D Folkes has been supplying NHS workers with 3D printed face shields. \nHowever\, new entrants to the market are finding themselves caught in a maze of requirements to have products certified to sell in the UK as PPE. These processes can be easily misunderstood – especially among the confusion and noise that the pandemic has created. \nTo help manufacturers understand the different types of PPE\, and the testing and certification process\, SGS experts Kevin Foy and Kelvin Shepherd will cover everything you need to know about getting your products placed on the market. \nAt the end of this one-hour session\, attendees will have the opportunity to pose their questions. As part of a global network of PPE experts and accredited laboratories\, both Kevin and Kelvin are well placed to advise on how you can ensure the compliance of your face masks and PPE products. \nThis webinar will help you to understand the steps you need to take and the timeframes involved to get your goods to market. \nTo find out more and to book your free place\, please click here. 
URL:https://staging.medilinkmidlands.com/event/webinar-manufacturing-face-masks-and-ppe-what-you-need-to-know/
CATEGORIES:Medilink Partner Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Medilink-Midlands-Logo-orange-final.jpg
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200928
DTEND;VALUE=DATE:20200929
DTSTAMP:20260410T033523
CREATED:20190923T123050Z
LAST-MODIFIED:20190923T123050Z
UID:18015-1601251200-1601337599@staging.medilinkmidlands.com
SUMMARY:SEHTA's 1st International MedTech Expo & Conference
DESCRIPTION:The SME focused healthcare event for driving collaborations between Business\, Care & Clinicians & Academics \nSEHTA’s 1st International MedTech Expo & Conference \nDevices\, Diagnostics\, Digital\nAt one EVENT & in one DAY \nOver the last 15 years\, South East Health Technologies Alliance (SEHTA) has developed an excellent reputation for support of its 1\,300 members\, especially SMEs\, through its one to one mentoring\, fund-finding\, consultancy and events programme. \nIn 2020\, for the first time\, SEHTA is organising a major new international event in London designed to take the programme of support to another level. \nWe cordially invite you to join us on Thursday 26th March 2020 for SEHTA’s first International MedTech Expo & Conference taking place at the Hilton London Tower Bridge. This event is aimed at SME’s\, Corporates\, Academics & NHS Healthcare Providers. \nThe conference and expo aims to help delegates: \nUnderstand: Make sense of the complexities of healthcare support and challenges of accessing the NHS \nFind: Funding opportunities (public sector\, private\, NHS) \nNavigate: Regulatory\, legal and IP issues \nIdentify: Current clinical challenges in the NHS \nAnd perhaps most of all…. Make new contacts leading to collaborative partnerships at the event and through our bespoke 1:1 partnering website\n(available from January 2020 to book your meetings) \nFor further information\, please click here to email SEHTA.
URL:https://staging.medilinkmidlands.com/event/sehtas-1st-international-medtech-expo-conference/
LOCATION:Hilton London Tower Bridge\, 5 More London Riverside\, London\, SE1 2BY
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200917T140000
DTEND;TZID=Europe/London:20200917T150000
DTSTAMP:20260410T033523
CREATED:20200810T091846Z
LAST-MODIFIED:20200810T091846Z
UID:18315-1600351200-1600354800@staging.medilinkmidlands.com
SUMMARY:Diagnosing the risk in diagnostics development; man versus machine
DESCRIPTION:Series of In-vivo devices\, Microfluidics and Diagnostics Webinars \nSeptember 2020 \nSEHTA and eg technology are delighted to announce a series of webinars on the topics of In-vivo devices\, Microfluidics and Diagnostics to enable you to continue to update your skillset and move your medical technologies and companies forward. \nEach session will run for 1 hour:  14:00 – 15:00 (UK time) \nThese webinars will be run via WEBEX – details on application \nThe design and development of Diagnostic devices within the medical industry is a complex process\, fraught with usability uncertainties. Many clinicians are reluctant to make a diagnosis without the confirmation of a device\, but devices cannot always be used in isolation as they do not have the full picture and patient knowledge of the clinician. This dichotomy makes the development of such devices often difficult. So\, how do we develop a diagnostics device which satisfies the product\, patient\, and clinician requirement specifications? Furthermore\, how can we develop a diagnostics strategy that addresses the codependence of diagnostic devices and their user? \nThis webinar will focus on what it takes to produce a diagnostics device which not only meets requirements but lives up to its marketing. Looking at the user and usability requirements\, how your device should be classified and the importance of creating a defined strategy\, we will discuss the human factors involved with diagnostics design and how total reliance on the device is not always the best option.  \nTopics to be covered include: \n\nThe key considerations in a diagnostics device development programme\nThe importance of identifying your product strategy early in your programme\nHow to keep usability and the end-user in mind throughout\nNavigating the regulatory process\nClosing the design loop – ensuring your end product does what you say it does!\n\nTarget audience for these webinars are: Medical Technology Entrepreneurs\, Medical Device Software Developers\, Technology Transfer Officers\, Medical Technology University Researchers\, IVD Developers\, Business Owners\, Executives\, Product Owners\, Regulatory Specialists within a company that need to understand the overall regulatory requirements for their medical devices to enable them to place a device on the market and to maintain access. All company sizes will find it useful. \nCosts to attend: \nEarly bird rate – book by 31st August 2020 \n£55 + VAT pp per webinar for members / £65 + VAT non-members \nAfter 31st August 2020 \n£65 +VAT pp per webinar for members / £75 + VAT non members \nNot a member of SEHTA – it’s free to join – https://www.sehta.co.uk/Post/sehta-membership \nFor more details\, and to book your place\, click here
URL:https://staging.medilinkmidlands.com/event/diagnosing-the-risk-in-diagnostics-development-man-versus-machine/
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200916T140000
DTEND;TZID=Europe/London:20200916T150000
DTSTAMP:20260410T033523
CREATED:20200810T091604Z
LAST-MODIFIED:20200810T091604Z
UID:18314-1600264800-1600268400@staging.medilinkmidlands.com
SUMMARY:Microfluidics; small technology\, big pitfalls
DESCRIPTION:Series of In-vivo devices\, Microfluidics and Diagnostics Webinars \nSeptember 2020 \nSEHTA and eg technology are delighted to announce a series of webinars on the topics of In-vivo devices\, Microfluidics and Diagnostics to enable you to continue to update your skillset and move your medical technologies and companies forward. \nEach session will run for 1 hour:  14:00 – 15:00 (UK time) \nThese webinars will be run via WEBEX – details on application \nIt is estimated that the Global Microfluidics Market will have a value of over USD 53 billion by the end of 2027\, but how much do you really know about Microfluidics and how it fits in to a design programme? \nThis webinar will look at the various development challenges when working with Microfluidics. Starting with an overview of applications and fabrication technologies\, we will then discuss the relationship between single use consumables and multi-use products with examples\, the different fluid handling technologies and then move on to the main developmental obstacle; identifying\, assessing and overcoming the many pitfalls associated with Microfluidics. \nThis webinar will cover: \n\nAn overview of Microfluidics and how it is incorporated into development programmes\nUnderstanding the different technologies available and identifying the most suitable option for your programme\nThe importance of identifying and assessing risks early in your programme and overcoming these development challenges\n\nTarget audience for these webinars are: Medical Technology Entrepreneurs\, Medical Device Software Developers\, Technology Transfer Officers\, Medical Technology University Researchers\, IVD Developers\, Business Owners\, Executives\, Product Owners\, Regulatory Specialists within a company that need to understand the overall regulatory requirements for their medical devices to enable them to place a device on the market and to maintain access. All company sizes will find it useful. \nCosts to attend: \nEarly bird rate – book by 31st August 2020 \n£55 + VAT pp per webinar for members / £65 + VAT non-members \nAfter 31st August 2020 \n£65 +VAT pp per webinar for members / £75 + VAT non members \nNot a member of SEHTA – it’s free to join – https://www.sehta.co.uk/Post/sehta-membership \nFor more details and to book\, click here
URL:https://staging.medilinkmidlands.com/event/microfluidics-small-technology-big-pitfalls/
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200915T140000
DTEND;TZID=Europe/London:20200915T150000
DTSTAMP:20260410T033523
CREATED:20200810T091214Z
LAST-MODIFIED:20200810T091214Z
UID:18313-1600178400-1600182000@staging.medilinkmidlands.com
SUMMARY:The Killer Issue: How to mitigate risk when designing in-vivo devices
DESCRIPTION:SEHTA & eg technology  \nSeries of In-vivo devices\, Microfluidics and Diagnostics Webinars \nSeptember 2020 \nSEHTA and eg technology are delighted to announce a series of webinars on the topics of In-vivo devices\, Microfluidics and Diagnostics to enable you to continue to update your skillset and move your medical technologies and companies forward. \nEach session will run for 1 hour:  14:00 – 15:00 (UK time) \nThese webinars will be run via WEBEX – details on application \nRisk goes hand in hand with medical device design and development – intervening in the human body will always have the potential to go wrong. But what happens when device limitations could result in serious injury or even death? Join egt director\, Danny Godfrey as he looks specifically at the design and development of in-vivo devices and how risks are identified\, managed\, and mitigated to minimize the risk of potentially catastrophic outcomes. \nStarting with a brief overview of the medical device development process\, this webinar will address the importance of examining the full use cycle of your device and identifying risks early on in your project – including less obvious and sometimes unseen obstacles – whilst ensuring full traceability throughout. \nTopics to be covered include: \n\nThe key things to consider from the outset of any development programme\nHow to identify the full spectrum of potential risks \nWhen in your programme this should happen\nThe importance of device classification and mapping risks against standards\nHow to mitigate risks to allow you to get on with your design\n\nTarget audience for these webinars are: Medical Technology Entrepreneurs\, Medical Device Software Developers\, Technology Transfer Officers\, Medical Technology University Researchers\, IVD Developers\, Business Owners\, Executives\, Product Owners\, Regulatory Specialists within a company that need to understand the overall regulatory requirements for their medical devices to enable them to place a device on the market and to maintain access. All company sizes will find it useful. \nCosts to attend: \nEarly bird rate – book by 31st August 2020 \n£55 + VAT pp per webinar for members / £65 + VAT non-members \nAfter 31st August 2020 \n£65 +VAT pp per webinar for members / £75 + VAT non members \nNot a member of SEHTA – it’s free to join – https://www.sehta.co.uk/Post/sehta-membership \nFor more information and to book\, click here
URL:https://staging.medilinkmidlands.com/event/the-killer-issue-how-to-mitigate-risk-when-designing-in-vivo-devices/
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200910T100000
DTEND;TZID=Europe/London:20200910T110000
DTSTAMP:20260410T033523
CREATED:20200810T113723Z
LAST-MODIFIED:20200810T113723Z
UID:18316-1599732000-1599735600@staging.medilinkmidlands.com
SUMMARY:R&D Tax Credits and Accounting for Development Expenditure
DESCRIPTION:Have you recently applied for UK Government funding grant or recently been awarded one?  Then this is the webinar for you! \nSEHTA and Edwards Chartered Accountants are pleased to launch their first webinar on R&D tax credits and accounting for companies who are engaged in developing new science or technology and who have recently received or in the process of applying for a UK government grant.\nDate: Thursday 10th September 2020 \nTime: 10:00 – 11:00 (UK Times) \nCosts: SEHTA Members: £65 + VAT per delegate / Non-Members:  £75 + VAT per delegate\n​Not a member of SEHTA? – it’s free to join\nThese webinars will be run via WEBEX – details on application \nOverview of the webinar \nR&D tax credits: \n\nDetails of the two schemes which are available (Small & RDEC)\nExample calculations to demonstrate the tax savings / refunds available to companies\nDetails of the procedure of making an R&D claim\nDetails of what costs qualify for R&D tax credits and eligibility criteria\nDetails of proposed future changes to the scheme and COVID-19 related tips\n\nAccounting for development expenditure: \n\nDetails of the two options available to companies\nPros and cons of both options and why a company may want to consider changing their accounting policy for development expenditure\nDetails of the procedure which can be implemented if a company decides to change its accounting policy for development expenditure including eligibility criteria\n\nTarget audience:  Any company which is engaged in developing new science or technology\, and any company which is currently in the process of applying for or has recently received a UK government grant. \nPlaces are limited so register today to guarantee your place \nClick here to book
URL:https://staging.medilinkmidlands.com/event/rd-tax-credits-and-accounting-for-development-expenditure/
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200904T130000
DTEND;TZID=Europe/London:20200904T143000
DTSTAMP:20260410T033523
CREATED:20200824T082519Z
LAST-MODIFIED:20200824T082519Z
UID:18336-1599224400-1599229800@staging.medilinkmidlands.com
SUMMARY:Lifescience Industry News Industry Spotlight
DESCRIPTION:Examining the UK response to Covid-19\nAhead of the Lifescience Industry Magazine being published\, Lifescience Industry Magazine is hosting a webinar\, on 4th September at 1 pm\, spotlighting some of the great stories of how the UK has responded to the pandemic. \nShowcasing how the life science and health tech sector worked\, collaborated and persevered during these challenging times. \nEach of Lifescience Industry’s partners will be introducing companies from across the UK\, further program details to follow shortly. \nConfirmed speakers include: \n\nJames Hindley\, Executive Director of Indoor Biotech\nDr Roberto Liddi\, Senior Vice President Quality Regulatory and IG Compliance at Sensyne Health\nNeil Cambell\, Chief Executive Officer for Inspiration Healthcare Group\nSven Bunn\, Life Sciences Programme Director at Barts Health NHS Trust\n\nLifescience Industry magazine is a collaboration between regional\, national and international life science partners. It includes the latest news and developments from the life science industry\, with editorial covering the complete health technology spectrum\, as well as funding\, trade and collaboration opportunities. \nTo register for this event\, click here
URL:https://staging.medilinkmidlands.com/event/lifescience-industry-news-industry-spotlight/
CATEGORIES:Medilink Partner Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200728T150000
DTEND;TZID=Europe/London:20200731T140000
DTSTAMP:20260410T033523
CREATED:20200713T105837Z
LAST-MODIFIED:20200713T105837Z
UID:18284-1595948400-1596204000@staging.medilinkmidlands.com
SUMMARY:InnovateUK Biomedical Catalyst FREE briefing webinars
DESCRIPTION:InnovateUK launch their next round of funding on the Biomedical catalyst on 27th July. \nFor your chance to find out more and ask questions join one of SEHTA’s free webinars. \nDiagnostics \n28th July (focus on Diagnostics) 15:00-16:00 (BST) \nDigital Health \n31st July (focus on Digital Health) 13:00-14:00 (BST) \nFree to attend \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n£30 million grant funding is available to UK health & life science SMEs for early & late-stage projects with length from 12-36 months and total project costs between £250\,000 and £4M. \nInnovate UK can provide 70% of total project costs for SMEs. \nOpen for applications on 27 July 2020 and deadline on 7 October 2020 \nThere are limited places to allow for effective discussion so SEHTA may not be able to host everyone. However\, they will record the sessions for later universal download. \nFor more information on the funding programme click here  \nThese webinars are free to attend. For more information\, please click here
URL:https://staging.medilinkmidlands.com/event/innovateuk-biomedical-catalyst-free-briefing-webinars/
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200714T100000
DTEND;TZID=Europe/London:20200714T120000
DTSTAMP:20260410T033523
CREATED:20200629T090815Z
LAST-MODIFIED:20200629T090815Z
UID:18273-1594720800-1594728000@staging.medilinkmidlands.com
SUMMARY:Post-COVID 19 Accessing the NHS Webinar
DESCRIPTION:SEHTA has\, over the last 15 years\, worked with over 300 SMEs to provide information on “How to Access the NHS” and produced 2 guides in 2018 & 2019 giving a detailed background of the process to access the NHS\, as well as case studies of companies who have experienced the up’s and down’s of the process. \nIn this webinar our CEO\, Dr David Parry and our COO\, Neil Roberts will present a pragmatic approach to help you get the NHS interested in your product and as part of your attendance\, we can also offer you a personal 15 min 1:1 session with David or Neil after the webinar.  Please note that a questionnaire will need to be completed prior to your session. \nDate: Tuesday 14th July 2020 \nWebinar Times: 10:00 – 12:00 (UK Time Zone) \n1:1 Session Times: 14:00 – 16:00 (UK Time Zone) \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCosts to attend: \n\n\n\nWebinar only \n£65+VAT pp for SEHTA Members \n£75+VAT pp for Non-members \n \nWebinar & 1:1 session  \n£80+VAT pp for SEHTA Members \n£90+VAT pp for Non-members \n \n\n\nNot a member of SEHTA – it’s free to join – click here to register\n\n\n\nThe webinar & 1:1 sessions will be run via WEBEX – details on application \nThe webinar will consist of: \n\nThe NHS as a marketplace for your product\nGetting through the system\nThe new normal- post COVID\n\nWe will also provide you with copies of our well received and comprehensive guides to help you access the NHS after the event – Read more here \n \nAs part of your attendance\, we can also offer you a personal 15 min 1:1 session with David or Neil after the webinar.  Please note that a questionnaire will need to be completed prior to your session and places are allocated on a first-come\, first-served basis – limited availability. \nThe target audience for these webinars is SMEs\, Start-ups\, Digital Health Developers\, Medical Technology Entrepreneurs\, Medical Device Software Developers\, Technology Transfer Officers\, Medical Technology University Researchers\, IVD Developers\, Business Owners\, Executives\, Product Owners\, within a company that need to understand the overall requirements for their medical devices to enable them to place a device on the market and to maintain access. All company sizes will find it useful. \nClick here to book
URL:https://staging.medilinkmidlands.com/event/post-covid-19-accessing-the-nhs-webinar/
CATEGORIES:Medilink Partner Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/accessing-the-nhs-guides.jpg
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200618T140000
DTEND;TZID=Europe/London:20200618T144500
DTSTAMP:20260410T033523
CREATED:20200611T111312Z
LAST-MODIFIED:20200611T111312Z
UID:18215-1592488800-1592491500@staging.medilinkmidlands.com
SUMMARY:Medilink WM: Visor PPE webinar with SATRA Technology
DESCRIPTION:Medilink West Midlands and SATRA Technology invite you to attend this PPE focused webinar session\, providing a walkthrough of the basics to make sure organisations are ready for visors testing certification. \nSATRA Technology\, a European Notified Body for PPE testing and certification will share valuable knowledge and experiences of testing and supporting industry to date. \nDate: Thursday 18th June \nTimes: 14:00 – 14:45 \nSimon Courtney\, Divisional Manager – Consumer Products Division at SATRA Technology will highlight: \n\nCommon errors and mistakes\, and advice on what you need to do for a smooth journey through this process\nThe benefit of having PPE certification and the consequences of not\, as outlined in the latest government publication; Guidance published for Small-Scale Manufacturers of COVID-19 Personal Protective Equipment\nThe end result and PPE certification\n\nThis 45-minute website will provide you with the advice\, and take away tips on how to successfully test your visor PPE product. \nPlease submit any questions in advance to ensure we cover this in the session. \nFor more information and to register please click here
URL:https://staging.medilinkmidlands.com/event/medilink-wm-visor-ppe-webinar-with-satra-technology/
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200331T103000
DTEND;TZID=Europe/London:20200331T154500
DTSTAMP:20260410T033523
CREATED:20200207T133917Z
LAST-MODIFIED:20200207T133917Z
UID:18060-1585650600-1585669500@staging.medilinkmidlands.com
SUMMARY:Software/AI Medical Device EU MDR CE Marking Workshop
DESCRIPTION:SEHTA and Psephos Biomedica next workshop is on Software / AI Medical Device EU MDR CE Marking. \nWhy attend? \nThere has been an explosion of software health technologies applying algorithms and artificial intelligence to address medical needs\, furthermore many traditional devices are adding software components or becoming digital. \nIn order to make these medical technologies available in Europe\, they must be CE marked which is currently governed by the Medical Device Directive and will be replaced in May 2020  by the new EU Medical Device Regulations (2017/745 & 746). \nDate:  Wednesday 31st March 2020 \nVenue:  Hill Dickinson\, Broadgate Tower\, 20 Primrose Street\, London EC2A 2EW \nTime:  10:30 – 15:45 \nCost:  SEHTA members fee: £270 + VAT / Non-Members: £320 + VAT per delegate \nNot a member of SEHTA?  It’s free to join – just click here \nFor more information and to register please click here
URL:https://staging.medilinkmidlands.com/event/software-ai-medical-device-eu-mdr-ce-marking-workshop/
LOCATION:Hill Dickinson\, Broadgate Tower\, 20 Primrose Street\, London\, EC2A 2EW
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200311T083000
DTEND;TZID=Europe/London:20200311T143000
DTSTAMP:20260410T033523
CREATED:20200124T105241Z
LAST-MODIFIED:20200124T105241Z
UID:18056-1583915400-1583937000@staging.medilinkmidlands.com
SUMMARY:How to increase quality & manufacturing processes through digitisation
DESCRIPTION:Medilink WM and MasterControl invite you to attend a free workshop to learn more about the changing medical device regulatory environments\, successfully navigating audits and the value of using digital solutions for managing quality and compliance. Offering attendees a better understanding of ‘How to be nimble in an ever-changing regulatory environment and easily manage the audit process with digitisation.’ \nHighly-knowledgeable life sciences industry experts will provide valuable insight on these topics and demonstrate how medical device and component manufacturers can position themselves for success. \nYou will hear from industry experts including Stephen Turnock\, Global Sales Director EMEA\, MasterControl and guest speaker Matthew Theobald\, Three Circles who will cover: \n\nMedical Device Audit Fundamentals\, MD SAP including the regulatory impact on audits\nAssessing your company’s current readiness for implementing a quality platform\, (MasterControl EBR)\nAn overview of the regulatory and quality management system requirements for a concept medical device\, understand the technical document that should be in place and explore risk management.\nImprove Product Quality & Operational Efficiency with Paperless Processes\n\nAttendees also have the opportunity to a private tour of the MTC facility. \nThis workshop will include opportunities to network and learn from your peers about their best practices and use of technology to navigate regulatory pathways and achieve compliance.
URL:https://staging.medilinkmidlands.com/event/how-to-increase-quality-manufacturing-processes-through-digitisation/
LOCATION:The MTC\, Ansty Park\, Coventry\, CV7 9JU
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200304T120000
DTEND;TZID=Europe/London:20200304T170000
DTSTAMP:20260410T033523
CREATED:20200106T140551Z
LAST-MODIFIED:20200106T140551Z
UID:18044-1583323200-1583341200@staging.medilinkmidlands.com
SUMMARY:Are you an Innovator working in mHealth?
DESCRIPTION:Aimed to give developers clear guidance\, helping to get the right market with the right product\, fit for NHS and worldwide quality standards \nThe NHS and national health bodies across the world are revolutionising services through the integration of digital health solutions\, leading to more patient-centered and efficient care. Frameworks guide the identification of health apps that will safely make the biggest impact in terms of improving outcomes. \nAs a developer\, it can be hard to know what technical requirements and evaluation will be imperative\, and how to navigate the system to ensure the right people know about your innovation. \nThis half day workshop aims to give developers clear guidance\, helping to get the right market with the right product\, fit for NHS and worldwide quality standards. Industry experts will provide practical advice\, with useful tools to future proof your innovation and be business ready. \nYou will hear from: \n-ORCHA Co-Founder & COO\, Tim Andrews & ORCHA Associate Paul Davies\n-Wayne Shirt and Marcus Hinde from NHS Digital\n-Medilink West Midlands and real life case studies. \nCome and be part of the day\, to learn: \n-What the app accreditation landscape is across the UK\, EU and globally\n-Deep dive into the Medical Device Regulations and what this means for you and your product\n-mHealth Regulation and technical Safety – What are the current regulations and what new requirements are coming shortly for mhealth?\n-Real life examples on how and where are Apps being used in clinical practice today? And what are the barriers and opportunities to making mhealth part of what is done in everyday clinical practice?\n-Useful\, practical take away tools\n-Networking opportunities \nProgramme: \n12:00 – Arrival\, registration and networking lunch \n12:45 – Presentations commence \n15:00 – Refreshment break \n17:00 – Event concludes \nBooking information: \nTo secure your place please complete the online booking form. Invoices will be issued once registration is complete. If you have any queries please click here to contact Zoe Heather. \nMedilink member – £20+VAT / Non-member – £35+VAT \n 
URL:https://staging.medilinkmidlands.com/event/are-you-an-innovator-working-in-mhealth/
LOCATION:Kuehne+Nagel Ltd\, 3 Avenue Road\, Birmingham\, West Midlands\, B6 4DU
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200213T180000
DTEND;TZID=Europe/London:20200213T213000
DTSTAMP:20260410T033523
CREATED:20200106T115504Z
LAST-MODIFIED:20200106T115504Z
UID:18043-1581616800-1581629400@staging.medilinkmidlands.com
SUMMARY:Medilink West Midlands Medical & Healthcare Business Awards
DESCRIPTION:Join Medilink West Midlands on Thursday 13 February 2020 to celebrate its 18th year supporting the West Midlands life sciences\, health care and med-tech community and showcase the ‘best of the best’ in the region. \nAs Medilink West Midlands proudly approaches its 18th year supporting the regions life sciences\, health care and med-tech community\, we invite you to join us on Thursday 13 February at our annual Medical and Healthcare Business Awards at the Burlington Hotel\, Birmingham. The West Midlands boasts a world-class innovation infrastructure\, with ambitious businesses delivering positive impact into health and care and with your help we want to shine the light on the brilliance in our region. \nWe want you – we know you’re out there! Why not apply or nominate an award candidate?  \nThis year we have six awards; \n\nStart-up\nDelivering innovation into health and care\nExport\nInnovation\nOutstanding Achievement\nSupply Chain\n\nClick here to find out more on each award category. \nAward benefits: \n\nAll shortlisted applicants will be invited to attend our awards on 13 February 2020 with two free tickets\nAll winners are automatically included in the Medilink UK National Awards on 1 April in Birmingham\, part of the Med-Tech Innovation Expo – The UK’s leading medical design and manufacturing technology event\nRegional and national publicity.\n\nJoin us to celebrate our 18th year anniversary and the success of our local community. \nTo find out more on how to apply or secure your place at the awards please click here
URL:https://staging.medilinkmidlands.com/event/medilink-west-midlands-medical-healthcare-business-awards/
LOCATION:The Burlington Hotel\, 126 New Street\, Birmingham\, B2 4JQ\, United Kingdom
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200213T103000
DTEND;TZID=Europe/London:20200213T160000
DTSTAMP:20260410T033523
CREATED:20200108T142119Z
LAST-MODIFIED:20200108T142119Z
UID:18051-1581589800-1581609600@staging.medilinkmidlands.com
SUMMARY:CE Marking and FDA Regulations Workshop
DESCRIPTION:SEHTA and Psephos Biomedica are running their next workshop on 13 February in London\, on CE Marking and FDA Regulations requirements. \nWhy attend? : Medical technology developers are faced with choices on which markets to access first. The EU and the US represent 2/3 of all spend on medical devices and so understanding what is required to access these two markets is essential. \nDate: Thursday 13th February 2020 \nVenue: Hill Dickinson\, Broadgate Tower\, 20 Primrose Street\, London EC2A 2EW \nTime: 10:30 – 16.00 \nCost: SEHTA members fee: £270 + VAT / Non-Members: £320 + VAT per delegate \nFor further information and to register\, please click here. \nNot a member of SEHTA? It’s free to join – just click here
URL:https://staging.medilinkmidlands.com/event/ce-marketing-and-fda-regulations-workshop/
LOCATION:Hill Dickinson\, Broadgate Tower\, 20 Primrose Street\, London\, EC2A 2EW
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="Clare Ansett":MAILTO:clare.ansett@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200130T090000
DTEND;TZID=Europe/London:20200130T160000
DTSTAMP:20260410T033523
CREATED:20191030T090548Z
LAST-MODIFIED:20191030T090548Z
UID:18024-1580374800-1580400000@staging.medilinkmidlands.com
SUMMARY:Bridging the Gap Midlands
DESCRIPTION:On Thursday 30 January 2020 the AHSN Network will host Bridging the Gap Midlands\, the next in a series of the popular Bridging the Gap events. This event will take place at Jurys Inn Hinckley Island Hotel in Leicestershire and is delivered by West Midlands and East Midlands AHSN. \nBridging the gap is aimed at health technology innovators and companies who are interested in accessing the NHS marketplace to improve health and care for patients and citizens\, and who have a product or service that is ready for scaling up. \nFree to attend\, the event will include a range of talks\, workshops\, 1 to 1 advice sessions and unique networking opportunities. It brings together a wide range of services available to industry from the AHSN Network and our partners under one roof. \nDownload an Event Flyer here \n \nDelegates will be able to get advice about how to make their engagement with the NHS sharper and more cost-effective. That means understanding how decisions are made in the NHS\, who makes the decisions and how to get their attention. \nJoin us to get a better understanding of: \n\nthe innovation landscape\, the factors that will affect the uptake of your product and how AHSNs can support you\nthe requirements for evidence\, and how to go about generating evidence\nthe ways AHSNs can help you access national resources and the national programmes you can apply for.\n\nOur previous Bridging the gap events have sold out well in advance\, so early booking is recommended. \nYou can register here
URL:https://staging.medilinkmidlands.com/event/bridging-the-gap-midlands/
LOCATION:Jurys Inn Hinckley Island Hotel\, Watling Street\, Burbage\, Hinckley\, LE10 3JA
CATEGORIES:Medilink Partner Event
ATTACH;FMTTYPE=image/png:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/BTG5_TwitterCard_1200x675.png
ORGANIZER;CN="EMAHSN":MAILTO:jayne.holgate1@nottingham.ac.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20191211T123000
DTEND;TZID=Europe/London:20191211T170000
DTSTAMP:20260410T033523
CREATED:20191008T131024Z
LAST-MODIFIED:20191008T131024Z
UID:18018-1576067400-1576083600@staging.medilinkmidlands.com
SUMMARY:mHealth App Developer Seminar
DESCRIPTION:Are you an innovator working in mHealth? \nSEHTA and ORCHA are organising our 2nd mHealth of 2019 on App Development on Wednesday 11th December in London. \nThis workshop aims to give developers clear guidance on exactly what mHealth innovators will need to do as an organisation to prepare for and conform to these regulations to ensure the transition is as smooth and efficient as it can be. \nDate: Wednesday 11 December 2019 \nVenue: Hill Dickinson\, Broadgate Tower\, 20 Primrose Street\, London EC2A 2EW \nTimes: 12:30 – 17:00 \nEarly-Bird Special Offer – Book before 31st October \nSEHTA Members £190 + VAT / non-members £255 + VAT pp \nNot a member of SEHTA? – it’s free to join\, click here to join \nFor further details and to book\, please click here.
URL:https://staging.medilinkmidlands.com/event/mhealth-app-developer-seminar-2/
LOCATION:Hill Dickinson\, Broadgate Tower\, 20 Primrose Street\, London\, EC2A 2EW
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191204
DTEND;VALUE=DATE:20191205
DTSTAMP:20260410T033523
CREATED:20191021T123315Z
LAST-MODIFIED:20191021T123315Z
UID:18021-1575417600-1575503999@staging.medilinkmidlands.com
SUMMARY:UK HealthTech 2019
DESCRIPTION:UK HealthTech brings together key speakers to discuss the major strategic issues and policy developments facing the life science and health technology sector. \nThis years themes will include sessions relating to: \n– Regulatory updates\n– Investor Workshops\n– Finance and Funding seminars\n– Support for spin out and early stage companies\n– NHS Access talks\n– Innovation in Healthcare Technologies \nJoin delegates to network\, meet collaborative partners and build business development opportunities.\nListen to a programme of valuable sector updates and gain insights and intelligence across the life science and healthcare sectors. \nAttending the conference provides you with the unique opportunity to engage with industry\, UK regulatory\, the clinical community\, procurement and funding bodies\, as well as to meet collaborative partners and build business development opportunities. \nThis valuable day of briefings and networking has global impact and excellent export opportunities. \nAttendance: (to register your interest please click here) \n-Members £95 + VAT \n-Non-Members £120 +VAT \nPartners: 10% discount \nExhibitor Packages (for further information please click here) \n-Members £500 +VAT \n-Non-Members £750 +VAT \nFor further details and to register your interest\, please click here.
URL:https://staging.medilinkmidlands.com/event/uk-healthtech-2019/
LOCATION:Park Plaza Cardiff\, Greyfriars Road\, Cardiff\, CF10 3AL\, United Kingdom
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="Medilink Wales":MAILTO:connects-nhs@mediwales.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20191121T103000
DTEND;TZID=Europe/London:20191121T153000
DTSTAMP:20260410T033523
CREATED:20191021T124458Z
LAST-MODIFIED:20191021T124458Z
UID:18022-1574332200-1574350200@staging.medilinkmidlands.com
SUMMARY:In Vitro Diagnostic (IVD) New IVDR CE Marking Workshop
DESCRIPTION:This seminar will provide you insights into the key regulatory changes of the IVDR\, to help you to prepare your organisation and your devices for IVDR compliance. \nCost: SEHTA members fee: £240 + VAT / Non-Members: £280 + VAT per delegate \nNot a member of SEHTA? It’s free to join – just click here \nThe Invitro Diagnostic Regulations are in transition and companies need to understand and prepare for these significant changes. Attendees will gain an understanding of: \n-The new IVD regulations (EU 2017/746)\, Device Classification and Key Time Lines\n-Significant differences between the current directive (98/79/EC) and the new IVD Regulations\n-The role and status of Notified Bodies\n-Outline of the Technical Documentation including Labelling and EUDAMED\n-Outline of the Quality System requirements\n-Outline of the Performance requirements/Clinical evidence\n-Outline of Post Market Surveillance requirements \nFor further information and to register\, please click here.
URL:https://staging.medilinkmidlands.com/event/in-vitro-diagnostic-ivd-new-ivdr-ce-marking-workshop/
LOCATION:Hempsons\, 100 Wood Street\, London\, EC2V 7AN\, United Kingdom
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20191016T103000
DTEND;TZID=Europe/London:20191016T163000
DTSTAMP:20260410T033523
CREATED:20190715T095440Z
LAST-MODIFIED:20190715T095440Z
UID:17990-1571221800-1571243400@staging.medilinkmidlands.com
SUMMARY:EU MDR Clinical Strategy & Evidence Requirements for CE Marking Workshop - 16 Oct\, London
DESCRIPTION:Wednesday 16th October 2019 \nHill Dickinson\, Broadgate Tower\, 20 Primrose Street\, London EC2A 2EW\, 10:30 – 16:00 \nSEHTA members fee – £250 + VAT per delegate  \nSEHTA non-members fee – £300 + VAT per delegate \nWhy attend \nClinical strategy\, evidence and evaluation are central to product approval and market access. \nThrough clinical data a company is able to ensure: \n  \n\nthat their medical device is able to obtain CE Marking and other regulatory approvals;\nthat the device performs clinically in both a safe and effective manner per the intended use and in the indicated patient population; and\nthat they are able to place it on the market supported by sufficient clinical evidence for user adoption and reimbursement.\n\n  \nIt is a requirement of the new EU Medical Device Regulation that a medical device company have a regulatory strategy and of the MDR and MEDDEV 2.7/1 rev 4 that the company have a clinical evaluation strategy. \nIn order to effectively market their device and generate sales\, organisations need to have considered well in advance the clinical elements for market access as failure to do so may put them back months\, through not understanding and obtaining appropriate data when initially gathering clinical evidence. \nNotified Bodies and regulatory authorities are placing greater emphasis on clinical evidence. Competent Authorities & regulators in other countries are also looking at clinical data and expecting up to date evidence. In addition\, purchasers of devices are increasing their requirements for clinical evidence that demonstrates good clinical outcomes and value (evidence-based medicine). The need for clinical evidence and evaluation is a core theme and needs to be captured to satisfy regulators\, notified bodies\, patients\, physicians\, procurement\, reimbursement agencies (e.g. NICE)\, etc. \nCompanies need to be prepared and have solutions in place to address this and their ongoing clinical requirements. Getting your clinical strategy wrong will delay approval and also market access. \nPlease note this is for Medical Device firms only – not Pharma or IVD \n  \nThis one-day workshop will give you: \n  \n\nAn overview of the new EU Medical Device CE Marking Process\nHelp you to maintain Access to the Market\nUnderstand the key areas of compliance required\nUnderstand the technical documentation that should be in place for each device\nGain a plan of action for implementation and CE Marking under the new legislation\n\n  \nTarget Market: C suite\, executives\, product owners\, medical officers\, regulatory and clinical specialists within a company that need to understand the overall clinical requirements for their medical devices to enable them to place a device on the market and to maintain access. All company sizes will find it useful. \nTo view an agenda for this event\, click here \nTo register for this event\, click here
URL:https://staging.medilinkmidlands.com/event/eu-mdr-clinical-strategy-evidence-requirements-for-ce-marking-workshop-16-oct-london/
LOCATION:Hill Dickinson\, Broadgate Tower\, 20 Primrose Street\, London\, EC2A 2EW
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20191001T093000
DTEND;TZID=Europe/London:20191001T163000
DTSTAMP:20260410T033523
CREATED:20190806T073521Z
LAST-MODIFIED:20190806T073521Z
UID:18006-1569922200-1569947400@staging.medilinkmidlands.com
SUMMARY:MPD Training Course: Strategic Implementation of European In Vitro Diagnostic Regulations
DESCRIPTION:Legal Manufacturers of In Vitro Diagnostic products need to be aware of the scope and implications of the new European In Vitro Diagnostics Regulations 2017/746. Organisations must be realistic and prepared. Not only for the impact of changes in the short-term\, but for the long-term implications to the development and maintenance of diagnostic products in the European Market. We only have until May 2022 to complete this compliance journey for some products\, so it is strategically critical that all impacted businesses have fully understood and assessed the impacts on their business. \nMedilink WM\, in conjunction with Acclaim Biomedical Consulting Ltd. is offering a one day workshop to focus on the implementation of European In Vitro Diagnostics Regulations. This will provide attendees with detailed understanding of strategic impacts and possible solutions which may be used to ensure compliance going forwards. \nWhy attend? \nBy attending this workshop you will: \nGain a thorough understanding of the changes and strategic consideration of the major impact areas of the revised regulations with indepth review of the major clauses of the regulation.\nHave the confidence and knowledge to review your own business and formulate plans to meet the transition to the IVDR based on this one day event\nGain insight and tools to plan and implement into your business strategy for continued access to the European market\, by the deadlines set in the new regulations\nLearn from other like minded business leaders\, on their challenges and strategies to achieve the necessary legal process.\nMeet the expert: \nManaging Director Richard Young has an extensive background in regulatory affairs in addition to GMP (quality assurance)\, GLP (laboratory testing) and GCP (clinical). Spanning over two decades\, these core skill areas have been developed with experience in products ranging from class 3 devices such as Orthopaedic implants (IIb) neurological robots\, through electromedical devices such as infusion systems and cardio vascular products. Richard brings a blend of pragmatism and experience to these disciplines that facilitates insightful problem solving approaches as well as solid solutions. \nRichard’s skills and experience includes such areas as the development and implementation of effective quality management systems\, auditing to ISO and FDA QSIT standards\, and operating at national and international level through industry associations including Eucomed\, ABHI and ABHI Technical Policy Group. \nTarget audience \nDesigned for business leaders with executive responsibilities as well as Quality Assurance and Regulatory Professionals. \nThis course quickly identifies the areas of strategic impact\, possible costs and the time lines associated with the new EU In Vitro Diagnostic Device Regulations. \nBooking information: \nDelegate Fee: \nEarly bird fee – Register your place before Friday 23 August and receive a 10% discount \nMember fee: £180+VAT \nNon-Member fee: £215+VAT \nTo secure your place please contact Zoe Heather at zoeh@medilinkwm.co.uk or call 0121 452 5630 \nInvoices will be sent once booking has been confirmed by Medilink WM.
URL:https://staging.medilinkmidlands.com/event/mpd-training-course-strategic-implementation-of-european-in-vitro-diagnostic-regulations/
LOCATION:MTIC\, 4 Greenfield Crescent\, Edgbaston\, B15 3BE
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190917T100000
DTEND;TZID=Europe/London:20190917T143000
DTSTAMP:20260410T033523
CREATED:20190805T140145Z
LAST-MODIFIED:20190805T140145Z
UID:18003-1568714400-1568730600@staging.medilinkmidlands.com
SUMMARY:WHO Patient Safety Day
DESCRIPTION:WHO Patient Safety Day is an annual event on 17th September. For 2019\, Loughborough University HFE Hub is collaborating with the Healthcare Safety Investigation Branch (HSIB) to offer this free networking event. \nHealthcare staff\, decision-makers\, commissioners\, managers and politicians are all invited. \n10: 00 Tea/Coffee \n10.30 Welcome and Introduction – Sue Hignett & HSIB Director \n11.00 HSIB Presentation – What we have achieved & Going Forward – HSIB Director \n12.  Lunch \n13.00 Panel Discussion \n14.30 Close \nFor further information and to book your place\, please click here.
URL:https://staging.medilinkmidlands.com/event/who-patient-safety-day/
LOCATION:Loughborough University\, Room 101 Schofield Building\, Loughborough\, LE11 3TT
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="Loughborough University":MAILTO:https://billetto.co.uk/e/373129/contact/new
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190917T093000
DTEND;TZID=Europe/London:20190917T163000
DTSTAMP:20260410T033523
CREATED:20190806T073027Z
LAST-MODIFIED:20190806T073027Z
UID:18005-1568712600-1568737800@staging.medilinkmidlands.com
SUMMARY:MPD Training Course: Impact & Assessment of European Medical Device Regulations
DESCRIPTION:Are you ready for the imminent new medical devices regulations applicable from May 2020? Implementation of the new regulations needs to be a priority for industry. In less than 10 months\, medical device regulations are set to change. With such a short timeline\, organisations need to act now to ensure minimal disruption to their organisation and its supply chain. \nMedilink WM\, in conjunction with Acclaim Biomedical Consulting Ltd. is offering a one day workshop to explore the new European regulations for medical devices including; \nThe impact the regulations will have on SMEs\, in regards to costs\nAn overview of the remaining short timeline\nNotified Bodies – impact on SMEs\, and how to overcome potential barriers\nThe changes to CE Marking\nWhy attend? \nBy attending this workshop you will: \nGain a stronger understanding of the new EU regulation structure and its impact to industry\, with a clear practical ‘next steps’ guide.\nFormulate a strategic approach – the immediate actions you need to consider to comply and how to move forward in this new environment\nMeet the expert: \nManaging Director Richard Young has an extensive background in regulatory affairs in addition to GMP (quality assurance)\, GLP (laboratory testing) and GCP (clinical). Spanning over two decades\, these core skill areas have been developed with experience in products ranging from class 3 devices such as Orthopaedic implants (IIb) neurological robots\, through electromedical devices such as infusion systems and cardio vascular products. Richard brings a blend of pragmatism and experience to these disciplines that facilitates insightful problem solving approaches as well as solid solutions. \nRichard’s skills and experience includes such areas as the development and implementation of effective quality management systems\, auditing to ISO and FDA QSIT standards\, and operating at national and international level through industry associations including Eucomed\, ABHI and ABHI Technical Policy Group. \nBooking information: \nDelegate Fee: \nEarly bird fee – Register your place before Friday 23 August and receive a 10% discount \nMember fee: £180+VAT \nNon-Member fee: £215+VAT \nTo secure your place please contact Zoe Heather at zoeh@medilinkwm.co.uk or call 0121 452 5630 \nInvoices will be sent once booking has been confirmed by Medilink WM.
URL:https://staging.medilinkmidlands.com/event/impact-assessment-of-european-medical-device-regulations/
LOCATION:MTIC\, 4 Greenfield Crescent\, Edgbaston\, B15 3BE
CATEGORIES:Medilink Partner Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190911T160000
DTEND;TZID=Europe/London:20190911T180000
DTSTAMP:20260410T033523
CREATED:20190806T071217Z
LAST-MODIFIED:20190806T071217Z
UID:18004-1568217600-1568224800@staging.medilinkmidlands.com
SUMMARY:Webinar: How do I make the transition from candidate selection through to proof-of-concept?
DESCRIPTION:Join Nikki Whitfield\, VP\, CDMO Services at Quotient Sciences and Claire Thompson\, CEO\, Agility Health Tech and discover how to transition from your candidate selection process and how to utilize a data driven approach to develop the right dosage forms to achieve proof-of-concept. \nThis webinar will explore screening techniques\, integrated approaches and phase-appropriate development strategies. \nLearning Points:\n• What is a suitable screening package for determining the physical properties of an API and what are the red-flags to watch out for?\n• How can the developability classification system (DCS) be used to streamline my formulation development program?\n• How will in-vitro testing and pre-clinical evaluation help me guide the clinical formulation?\n• Will a pre-clinical formulation be suitable for clinical use?\n• Could a simple pharmacy preparation be suitable for my FIH trial or will a manufactured dosage form be required?\n• How can we bridge from pharmacy preparations to GMP solid oral dosage forms that will be robust and scalable?\n• How can you avoid common development pitfalls and ensure future success? \nTo register please click here. \nwww.quotientsciences.com
URL:https://staging.medilinkmidlands.com/event/webinar-how-do-i-make-the-transition-from-candidate-selection-through-to-proof-of-concept/
CATEGORIES:Medilink Partner Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190911T090000
DTEND;TZID=Europe/London:20190911T170000
DTSTAMP:20260410T033523
CREATED:20190722T115331Z
LAST-MODIFIED:20190722T115331Z
UID:17993-1568192400-1568221200@staging.medilinkmidlands.com
SUMMARY:Monitoring and supporting Patients across all healthcare settings
DESCRIPTION:MediWales is collaborating with the West of England Academic Health Science Network (AHSN) to deliver this conference which will focus on monitoring and supporting patients outside the hospital setting (at home\, in nursing and care homes) to specifically enable the measurement of vital signs to calculate a Nation Early Warning Score (NEWS) which is used when delivering care. \nFree delegate places are available to NHS professionals\, research and industry communities\, from both sides of the bridge. We would also like to extend an invitation to companies who have or are developing various approaches to track vital signs. Though this is not about intensive care monitoring – during the event it will be considered how these tools could be used in a community setting. This would include the recording of observations\, dashboards\, wearable devices\, remote monitoring\, devices that aid recording of observation or identifying deterioration with a particular interest in wearable and non-contact tech for those with Learning Disabilities. \nThis event will discuss the challenges and technical issues faced in the community care setting and look at the development of potential clinical / industry collaborations to address the issues in this area. There will also be information on the support and funding available to take projects forward. \nHear from speakers from the AHSN who will present their work on the National Early Warning Score (NEWS) and from Welsh clinical colleagues who will showcase their plan going forward. An insightful look at where automation of technologies and clinical pathways could be accessible to improve an ever evolving process. \nFor further information and to book your place\, please click here.
URL:https://staging.medilinkmidlands.com/event/monitoring-and-supporting-patients-across-all-healthcare-settings/
LOCATION:Coldra Court Hotel\, Chepstow Road\, Langstone\, Newport\, NP18 2LX
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="Medilink Wales":MAILTO:connects-nhs@mediwales.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190902T120000
DTEND;TZID=Europe/London:20190902T160000
DTSTAMP:20260410T033523
CREATED:20190819T121717Z
LAST-MODIFIED:20190819T121717Z
UID:18013-1567425600-1567440000@staging.medilinkmidlands.com
SUMMARY:Clinical Trials Masterclass
DESCRIPTION:CLINICAL TRIALS MASTERCLASS:\nStart with the end in mind \nMonday 2 September\n12 pm – 4 pm\nBoardroom | BioCity\, Nottingham \nPresented by NICE\, Arthur Gallagher and Remap Consulting \nIf you are a biotech company thinking about selling to a larger pharmaceutical company or going to market alone\, it is important that early clinical plans incorporate the needs of the final decision makers\, as well as the regulatory bodies. \nNICE Scientific Advice can help to shape clinical trial protocols and early modelling plans to ensure that evidence generation is targeted at an early to stage to provide the data required at the end of the process\, when a technology is appraised by NICE or other HTA bodies. \nArthur Gallagher will focus on the planning stage of trials and advise when to engage with the Broker and important insurance issues to be aware of. \nRemap Consulting will discuss the importance of obtaining payer scientific advice for achieving pricing and reimbursement success across the EU. \nThis event is free for all based at BioCity and Alderley Park.
URL:https://staging.medilinkmidlands.com/event/clinical-trials-masterclass/
LOCATION:We are Pioneer Group Nottingham\, Innovation Building\, (formerly BioCity)\, Pennyfoot Street\, Nottingham\, NG1 1GF\, United Kingdom
CATEGORIES:Medilink Partner Event
END:VEVENT
END:VCALENDAR